Literature DB >> 30607124

Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.

A Bouchard-Fortier1, N N Baxter2,3, R Sutradhar4, K Fernandes4, X Camacho4, P Graham1, M L Quan1.   

Abstract

Background and
Objectives: Contralateral prophylactic mastectomy (cpm) has been increasingly common among women with unilateral invasive breast cancer (ibca) even though the data that support it are limited. Using a population-based cohort, the objectives of the present study were to describe factors predictive of cpm in young women (≤35 years) with ibca and to evaluate the impact of the procedure on mortality.
Methods: All women diagnosed during 1994-2003 and treated with cpm were identified from the Ontario Cancer Registry. Logistic regression was used to identify patient and tumour factors associated with the use of cpm. Multivariate analyses were used to assess the effect of cpm on recurrence and mortality.
Results: Of 614 women identified, 81 underwent cpm (13.2%). On multivariable analysis, factors associated with cpm included negative lymph node status, negative estrogen receptor status, and initial breast-conserving surgery with re-excision. At follow-up, breast cancer-specific mortality was similar for women who did and did not undergo cpm. Conclusions: Use of cpm in young women with ibca (compared with non-use) was not associated improved breast cancer-specific mortality. Factors found to be predictive of cpm were negative lymph node status, negative estrogen receptor status, and initial breast-conserving surgery followed by re-excision.

Entities:  

Keywords:  Contralateral prophylactic mastectomy; breast cancer; young women

Mesh:

Year:  2018        PMID: 30607124      PMCID: PMC6291287          DOI: 10.3747/co.25.4169

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  29 in total

1.  An application of capture-recapture methods to the estimation of completeness of cancer registration.

Authors:  S C Robles; L D Marrett; E A Clarke; H A Risch
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

2.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.

Authors:  A C Voogd; M Nielsen; J L Peterse; M Blichert-Toft; H Bartelink; M Overgaard; G van Tienhoven; K W Andersen; R J Sylvester; J A van Dongen
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

3.  Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.

Authors:  Laura Kruper; Rondi M Kauffmann; David D Smith; Rebecca A Nelson
Journal:  Ann Surg Oncol       Date:  2014-07-22       Impact factor: 5.344

4.  Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.

Authors:  Isabelle Bedrosian; Chung-Yuan Hu; George J Chang
Journal:  J Natl Cancer Inst       Date:  2010-02-25       Impact factor: 13.506

5.  Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.

Authors:  S K McDonnell; D J Schaid; J L Myers; C S Grant; J H Donohue; J E Woods; M H Frost; J L Johnson; D L Sitta; J M Slezak; T B Crotty; R B Jenkins; T A Sellers; L C Hartmann
Journal:  J Clin Oncol       Date:  2001-10-01       Impact factor: 44.544

6.  Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.

Authors:  Katharine Yao; Andrew K Stewart; David J Winchester; David P Winchester
Journal:  Ann Surg Oncol       Date:  2010-05-12       Impact factor: 5.344

7.  Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.

Authors:  E A Peralta; J D Ellenhorn; L D Wagman; A Dagis; J S Andersen; D Z Chu
Journal:  Am J Surg       Date:  2000-12       Impact factor: 2.565

8.  Introduction to the Analysis of Survival Data in the Presence of Competing Risks.

Authors:  Peter C Austin; Douglas S Lee; Jason P Fine
Journal:  Circulation       Date:  2016-02-09       Impact factor: 29.690

9.  Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.

Authors:  Kelly Metcalfe; Shelley Gershman; Parviz Ghadirian; Henry T Lynch; Carrie Snyder; Nadine Tung; Charmaine Kim-Sing; Andrea Eisen; William D Foulkes; Barry Rosen; Ping Sun; Steven A Narod
Journal:  BMJ       Date:  2014-02-11

10.  Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.

Authors:  Judy C Boughey; Deanna J Attai; Steven L Chen; Hiram S Cody; Jill R Dietz; Sheldon M Feldman; Caprice C Greenberg; Rena B Kass; Jeffrey Landercasper; Valerie Lemaine; Fiona MacNeill; David H Song; Alicia C Staley; Lee G Wilke; Shawna C Willey; Katharine A Yao; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2016-07-28       Impact factor: 5.344

View more
  3 in total

1.  Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015.

Authors:  Allison W Kurian; Alison J Canchola; Cindy S Ma; Christina A Clarke; Scarlett L Gomez
Journal:  Cancer       Date:  2019-11-21       Impact factor: 6.860

2.  Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer.

Authors:  Akshara Singareeka Raghavendra; Hala F Alameddine; Clark R Andersen; Jesse C Selber; Abenaa M Brewster; Carlos H Barcenas; Abigail S Caudle; Banu K Arun; Debu Tripathy; Nuhad K Ibrahim
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 3.  Imaging in Locoregional Management of Breast Cancer.

Authors:  Christiane K Kuhl; Constance Lehman; Isabelle Bedrosian
Journal:  J Clin Oncol       Date:  2020-05-22       Impact factor: 44.544

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.